← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

▼ SELL

$ Value

$322K

Shares

3,000

Price

$107

Filed

May 20

Insider

Name

Coleman Mark

Title

CIK

0001658379

Roles

Director

Transaction Details

Transaction Date

2025-05-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

54,137

Footnotes

Represents the sale of underlying shares of previously exercised stock options. | Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65. | Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.

Filing Info

Accession No.

0000950170-25-075539

Form Type

4

Issuer CIK

0001579428

Coleman Mark's History

Date Ticker Type Value
2026-02-26 AXSM $4.0M
2026-02-23 AXSM M $31K
2026-02-23 AXSM M $0
2026-02-20 AXSM M $62K
2026-02-20 AXSM M $0
2026-02-10 AXSM M $42K
2026-02-10 AXSM M $0
2025-09-08 AXSM $102K
2025-09-08 AXSM $37K
2025-09-08 AXSM $62K

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22